Introduction
============

Postoperative new-onset atrial fibrillation (PNAF) is very common after cardiac surgery. The inflammatory response due to surgery and cardiopulmonary bypass (CPB) may contribute to PNAF by inducing atrial dysfunction \[[@B1]\]. Corticosteroids reduce the inflammatory response and may thus reduce atrial dysfunction and PNAF \[[@B2]\]. The aim of this study was to determine whether dexamethasone protects from left atrial dysfunction and PNAF in cardiac surgical patients.

Methods
=======

Patients undergoing cardiac surgery were randomized to a single dose of dexamethasone (1 mg/kg) or placebo after inducing anesthesia. Transesophageal echocardiography was performed in patients after CPB. The primary outcome was left atrial total ejection fraction (LA-TEF) after sternal closure; secondary outcomes included left atrial diameter and PNAF, detected by Holter monitoring.

Results
=======

Sixty-two patients were included. Baseline characteristics were well balanced. Postoperative LA-TEF was 36.4% in the dexamethasone group and 40.2% in the placebo group (*P*= 0.15) (Figure [1](#F1){ref-type="fig"}). Secondary echocardiographic outcomes were also insignificant (Table [1](#T1){ref-type="table"}). The incidence of PNAF was 30% in the dexamethasone group and 39% in the placebo group (*P*= 0.47).
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###### 

Secondary postoperative echocardiographic parameters in both groups

  Parameter     Dexamethasone   Placebo   *P***value**
  ------------- --------------- --------- --------------
  LA-TEF        36.4            40.2      0.15
  LA diameter   4.6             4.3       0.19
  LA area       16.0            16.4      0.81

Conclusion
==========

Intraoperative high-dose dexamethasone did not have any protective effect on postoperative LA-TEF or dimension and did not reduce the risk of PNAf in cardiac surgical patients.
